{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:33:01Z","timestamp":1787142781260,"version":"build-2736575974"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"Suppl 1","license":[{"start":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T00:00:00Z","timestamp":1775433600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Paroxysmal nocturnal hemoglobinuria (PNH) is a rare acquired hematopoietic disorder requiring careful therapeutic management. In resource-limited settings, traditional treatments may carry significant risks. A 32-year-old female with PNH developed acute pancreatitis 10 months after initiation of danazol and deflazacort therapy. Initial presentation included typical hemoglobinuria, pancytopenia, and indirect hyperbilirubinemia. Flow cytometry confirmed PNH clones despite a negative Ham\u2019s test. Treatment with danazol 200 mg twice daily and deflazacort 30 mg daily initially provided clinical improvement. Subsequently, the patient developed pigment nephropathy requiring dialysis, followed by severe acute pancreatitis with markedly elevated pancreatic enzymes (amylase: 3370 U\/L and lipase: 12,478 U\/L). Ultrasonography revealed a bulky pancreatic head with heterogeneous echotexture. Other causes of pancreatitis were excluded. Both medications were discontinued, and conservative management led to clinical recovery. This case represents drug-induced pancreatitis, a rare but serious complication of PNH therapy. Both danazol and corticosteroids have been independently associated with acute pancreatitis in the literature, though reports remain sparse. The concurrent use of these agents may have contributed synergistically to pancreatic inflammation. The patient\u2019s clinical course, including androgenic side effects and temporal relationship with drug exposure, supports the causal association. Healthcare providers managing PNH in African settings must remain vigilant for drug-induced pancreatitis when using traditional therapies. Enhanced monitoring protocols and improved access to safer complement inhibitors are essential for optimizing patient outcomes while minimizing treatment-related complications in resource-limited environments.<\/jats:p>","DOI":"10.4103\/aam.aam_518_25","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:00:54Z","timestamp":1775545254000},"page":"S156-S161","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Acute Pancreatitis as a Therapeutic Complication in Case of Paroxysmal Nocturnal Hemoglobinuria"],"prefix":"10.4103","volume":"25","author":[{"given":"M Sai Rohith","family":"Reddy","sequence":"first","affiliation":[{"name":"Department of General Medicine, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira Ashish","family":"Dhere","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manaswini","family":"Edara","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanamatareddy Sai Abhinav","family":"Reddy","sequence":"additional","affiliation":[{"name":"Department of General Medicine, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,4,6]]},"reference":[{"key":"R2-20260819","doi-asserted-by":"crossref","first-page":"17028","DOI":"10.1038\/nrdp.2017.28","article-title":"Paroxysmal nocturnal haemoglobinuria","volume":"3","author":"Hill","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"R4-20260819","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","article-title":"Natural history of paroxysmal nocturnal hemoglobinuria","volume":"333","author":"Hillmen","year":"1995","journal-title":"N Engl J Med"},{"key":"R5-20260819","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","article-title":"The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria","volume":"355","author":"Hillmen","year":"2006","journal-title":"N Engl J Med"},{"key":"R6-20260819","doi-asserted-by":"crossref","first-page":"4123","DOI":"10.1182\/blood-2007-06-095646","article-title":"Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria","volume":"110","author":"Hillmen","year":"2007","journal-title":"Blood"},{"key":"R7-20260819","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1053\/j.gastro.2013.01.068","article-title":"The epidemiology of pancreatitis and pancreatic cancer","volume":"144","author":"Yadav","year":"2013","journal-title":"Gastroenterology"},{"key":"R8-20260819","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bpg.2007.10.007","article-title":"Epidemiology, aetiology and outcome of acute and chronic pancreatitis: An update","volume":"22","author":"Spanier","year":"2008","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"R9-20260819","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/BF02822386","article-title":"Acute pancreatitis in Sowetan Africans. A disease with high mortality and morbidity","volume":"21","author":"John","year":"1997","journal-title":"Int J Pancreatol"},{"key":"R10-20260819","first-page":"83","article-title":"Acute pancreatitis: Demographics, aetiological factors and outcomes in a regional hospital in South Africa","volume":"46","author":"Anderson","year":"2008","journal-title":"S Afr J Surg"},{"key":"R11-20260819","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF02031976","article-title":"Danazol induced pancreatitis and hepatitis","volume":"9","author":"Chevalier","year":"1990","journal-title":"Clin Rheumatol"},{"key":"R12-20260819","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/oxfordjournals.humrep.a138651","article-title":"Acute pancreatitis associated with danazol treatment for endometriosis","volume":"9","author":"Balasch","year":"1994","journal-title":"Hum Reprod"},{"key":"R13-20260819","doi-asserted-by":"crossref","first-page":"e0231883","DOI":"10.1371\/journal.pone.0231883","article-title":"Drug induced pancreatitis: A systematic review of case reports to determine potential drug associations","volume":"15","author":"Wolfe","year":"2020","journal-title":"PLoS One"},{"key":"R14-20260819","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.mayocp.2024.03.019","article-title":"Pancreatitis as a potential consequence of danazol therapy for telomere biology disorders","volume":"99","author":"McCullough","year":"2024","journal-title":"Mayo Clin Proc"},{"key":"R15-20260819","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.cgh.2006.11.023","article-title":"Drug-induced acute pancreatitis: An evidence-based review","volume":"5","author":"Badalov","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R16-20260819","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1001\/jamainternmed.2013.2737","article-title":"Association of oral glucocorticoid use with an increased risk of acute pancreatitis: A population-based nested case-control study","volume":"173","author":"Sadr-Azodi","year":"2013","journal-title":"JAMA Intern Med"},{"key":"R17-20260819","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJM199404283301706","article-title":"Acute pancreatitis","volume":"330","author":"Steinberg","year":"1994","journal-title":"N Engl J Med"},{"key":"R18-20260819","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40780-019-0134-6","article-title":"Analysis of the association of administration of various glucocorticoids with development of acute pancreatitis using US food and drug administration adverse event reporting system (FAERS)","volume":"5","author":"Nango","year":"2019","journal-title":"J Pharm Health Care Sci"},{"key":"R19-20260819","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1182\/blood-2014-02-522128","article-title":"Paroxysmal nocturnal hemoglobinuria","volume":"124","author":"Brodsky","year":"2014","journal-title":"Blood"},{"key":"R20-20260819","first-page":"408","article-title":"Variable effects of danazol on endometriosis at 4 low-dose levels","volume":"59","author":"Dmowski","year":"1982","journal-title":"Obstet Gynecol"},{"key":"R21-20260819","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","article-title":"Classification of acute pancreatitis-2012: Revision of the Atlanta classification and definitions by international consensus","volume":"62","author":"Banks","year":"2013","journal-title":"Gut"}],"container-title":["Annals of African Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_518_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T12:01:27Z","timestamp":1787140887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aam.aam_518_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,6]]},"references-count":19,"journal-issue":{"issue":"Suppl 1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/aam.aam_518_25","relation":{},"ISSN":["1596-3519","0975-5764"],"issn-type":[{"value":"1596-3519","type":"print"},{"value":"0975-5764","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,6]]},"assertion":[{"value":"2025-09-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-09","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}